Ikerchem will attend the European Cancer Cluster Partnering event that will be held in Toulouse, France, next week.
Our team has arranged various meetings with big pharma companies that have shown their interest in discussing the licensing opportunities of those oncology products in advanced preclinical stage available in our pipeline.
In addition, private investors have shown their interest in meeting with Ikerchem at the ECCP to discuss the possibility to co-develop our oncology drug candidates.